Silexion Therapeutics Corp (SLXNW) Warrants
Each SLXNW warrant gives the holder the right to buy 1/32,404 share of Silexion Therapeutics Corp at $372,600 per share, until August 15, 2029. The stock last closed at $1.50, below the strike, so the warrant is out of the money. Silexion Therapeutics Corp has a market value of about $974.29K. There are 5.75M listed warrants; exercising all of them would add 0.0% to the 649.53K shares outstanding.
Silexion Therapeutics Corp reports its business to the SEC as “Biological Products, (No Diagnostic Substances)”, with its head office in Ramat Gan, Israel; it is incorporated in the Cayman Islands. Its latest SEC filing was on November 19, 2026: current report (other events), form 8-K. The warrant closed at $0.0041 on November 19, 2026, down 89% from $0.0362 on November 19, 2025. SLXN trades at 0.0004% of the strike; it would have to rise about 248,400-fold to reach it.
Why is the strike so large? Silexion Therapeutics Corp has combined its shares in one or more reverse splits. The strike is quoted per whole share, so it rose each time, and each warrant now buys only 1/32,404 of a share. Exercising one warrant costs $11.50.
Thinly traded: SLXNW traded about $418 a day over the last 30 days, and on only 17 of 22 trading days. With so little trading you may not be able to buy or sell near the price shown; use a limit order.
Key terms
- Strike per share
- $372,600
- Shares per warrant
- 1/32,404
- Cash to exercise one warrant
- $11.50
- Expiry
- 2029-08-15
- Redemption trigger
- none stated
- Cashless exercise
- allowed
- Break-even stock price
- $372,733
From the issuer's S-1/A (2026-08-10).
Exercise calculator
Each warrant buys 1/32,404 share at $372,600. Before expiry a warrant usually sells for more than its exercise value, because it still has time left. Fees and taxes are not included. Arithmetic, not investment advice.
Company and stock
- Company
- Silexion Therapeutics Corp
- Underlying stock
- SLXN
- Share price
- $1.50
- Market cap
- $974.29K
- Shares outstanding
- 649.53K
- 12-month range
- $1.44 – $760.08
- 12-month change
- -100%
- Value of all listed warrants
- $23.58K (2.4% of market cap)
- Industry
- Biological Products, (No Diagnostic Substances)
- Head office
- Ramat Gan, Israel
- Incorporated in
- Cayman Islands
Market cap is the last share price times shares outstanding (as of 2026-11-12). Industry and head office are as the company reports them to the SEC. All SEC filings for this company.
Model value Pro · free for now
Dilution
- Shares outstanding
- 649.53K
- Listed warrants
- 5.75M
- Dilution if all exercised
- 0.0%
Warrant count from the notes to the company's financial statements. Confidence: medium.
Filings
- 8-KCurrent report: other events
- 8-KCurrent report: results
- 10-QQuarterly report
- 8-KCurrent report: holders' rights changed; charter or bylaws changed; other events Key
- 8-KCurrent report: other events
- S-3Registration of shares for sale
- 8-KCurrent report: charter or bylaws changed; shareholder vote results
- DEFA14AMore proxy material
- DEF 14AProxy for a shareholder vote
- 8-KCurrent report: investor update
The company's latest SEC filings, checked every night. Insider trades and routine SEC paperwork are left out. All SEC filings for this company.
Events
- Reverse split 1:24 eff
- Terms source: S-1/A
- Reverse split 1:10
- Reverse split 1:15
- Reverse split 1:9
Questions about SLXNW
When does the SLXNW warrant expire?
SLXNW expires on August 15, 2029.
What is the strike price of SLXNW?
$372,600 per share; each warrant converts into 1/32,404 share, so exercising one warrant costs $11.50.
Can Silexion Therapeutics Corp redeem the SLXNW warrants early?
The source filing we read lists no stock-price redemption trigger.
How many SLXNW warrants are outstanding?
5.75M listed warrants, equal to 0.0% dilution if all are exercised.
Related warrants
Get an email when alerts open
Follow SLXNW with the button at the top to get its alerts. Alerts are coming soon; leave your email and we will tell you when they open.

